Zupancic, CEO of Baltimore fitness company, died after years of battling ovarian cancer, according to a social media post by ...

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

The electronic health record (EHR)–based symptom inventory identified symptom prevalence and associated comorbidities, but no ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...

Professor Park Joon-sik of obstetrics and gynecology at Soonchunhyang University Bucheon Hospital announced on the 14th that ...

"It feels like we have been massively let down,” said Lindsey Rice after her sister Rhian Butlin was diagnosed with stage 4 ...

I don't want to be explaining to my daughters why we've still failed to make progress on gynaecological cancers, writes Elise ...

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

Niraparib maintenance has a tolerable safety profile in patients with ovarian cancer, with hematologic toxicities being “the primary concern,” according to researchers. They e ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.